USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
HEALIONICS CORPORATION
Address:
2121 N 35th St
SEATTLE, WA
Phone:
N/A
URL:
N/A
EIN:
208593151
DUNS:
801372066
Number of Employees:
7
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase II $909,165.00 1
STTR Phase I $116,418.00 1

Award List:

Artificial Cornea Using New Biomaterials

Award Year / Program / Phase:
2009 / STTR / Phase I
Award Amount:
$116,418.00
Agency:
HHS
Principal Investigator:
Max Maginness
Research Institution:
UNIVERSITY OF WASHINGTON
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): Artificial Cornea Using New Biomaterials PD/PI Maxwell Maginness PhD Project Summary/Abstract. We propose to advance the development of a novel artificial cornea design enabled by a new biomaterial technology permitting facile integration and sclera tissue… More

Anti-Infective Dermal Integration Sleeves for Needle Free Dialysis Access Devices

Award Year / Program / Phase:
2012 / SBIR / Phase II
Award Amount:
$909,165.00
Agency:
HHS
Principal Investigator:
Andrew Marshall – 425-818-1987
Abstract:
DESCRIPTION (provided by applicant): Significance: End Stage Renal Disease (ESRD) affects a rapidly growing population likely to exceed 1 million patients in the US by 2020. The standard treatment of 3 times per week hemodialysis (HD) has high complicationrates and infection risks, results in… More